Epiminder Limited (ASX:EPI)

Australia · Delayed Price · Currency is AUD

0.2900

0.00 (0.00%)

At close: Sep 18, 2026

Market Cap	62.83M
Revenue (ttm)	2.13M +379.1%
Net Income	-42.73M
EPS	-0.28
Shares Out	216.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,705
Open	0.2950
Previous Close	0.2900
Day's Range	0.2900 - 0.2950
52-Week Range	0.2500 - 1.4900
Beta	n/a
Analysts	Buy
Price Target	2.22 (+665.52%)
Earnings Date	Aug 31, 2026

About Epiminder

Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol EPI

Full Company Profile

Financial Performance

In fiscal year 2026, Epiminder's revenue was 2.13 million, an increase of 379.10% compared to the previous year's 445,000. Losses were -42.73 million, 34.5% more than in 2025.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for EPI stock is "Buy." The 12-month stock price target is $2.22, which is an increase of 665.52% from the latest price.

Price Target

$2.22

(665.52% upside)

Analyst Consensus: Buy

Stock Forecasts